These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 18756483)

  • 1. The hepatitis C virus-associated dysmetabolic syndrome.
    Lonardo A; Loria P
    Hepatology; 2008 Sep; 48(3):1018-9; author reply 1019. PubMed ID: 18756483
    [No Abstract]   [Full Text] [Related]  

  • 2. [HCV infection and liver steatosis].
    Cheng J; Zhang JQ
    Zhonghua Gan Zang Bing Za Zhi; 2009 Nov; 17(11):804-6. PubMed ID: 19958635
    [No Abstract]   [Full Text] [Related]  

  • 3. HCV infection and metabolic syndrome: which is the chicken and which is the egg?
    Negro F
    Gastroenterology; 2012 May; 142(6):1288-92. PubMed ID: 22537435
    [No Abstract]   [Full Text] [Related]  

  • 4. [Hepatitis C virus-associated and metabolic steatosis. Different or overlapping diseases?].
    Lonardo A; Loria P; Adinolfi LE; Andreana A; Ruggiero G; Carulli N
    Ann Ital Med Int; 2005; 20(1):10-22. PubMed ID: 15859390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis C virus and liver steatosis: is it the virus? Yes it is, but not always.
    Negro F
    Hepatology; 2002 Nov; 36(5):1050-2. PubMed ID: 12395313
    [No Abstract]   [Full Text] [Related]  

  • 6. Concluding remarks: metabolic syndrome, liver and HCV.
    Cortez-Pinto H
    Aliment Pharmacol Ther; 2005 Nov; 22 Suppl 2():83-5. PubMed ID: 16225481
    [No Abstract]   [Full Text] [Related]  

  • 7. Hepatitis C, insulin resistance and diabetes: clinical and pathogenic data.
    Serfaty L; Capeau J
    Liver Int; 2009 Mar; 29 Suppl 2():13-25. PubMed ID: 19187069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human immunodeficiency virus is the major determinant of steatosis and hepatitis C virus of insulin resistance in virus-associated fatty liver disease.
    Guaraldi G; Lonardo A; Ballestri S; Zona S; Stentarelli C; Orlando G; Carli F; Carulli L; Roverato A; Loria P
    Arch Med Res; 2011 Nov; 42(8):690-7. PubMed ID: 22227046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pathomechanism of metabolic disorders in HCV infection].
    BoroĊ„-Kaczmarska A
    Przegl Epidemiol; 2006; 60(4):701-5. PubMed ID: 17682751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis C virus and glucose and lipid metabolism.
    Alaei M; Negro F
    Diabetes Metab; 2008 Dec; 34(6 Pt 2):692-700. PubMed ID: 19195632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-alcoholic steatohepatitis: an overview.
    Shifflet A; Wu GY
    J Formos Med Assoc; 2009 Jan; 108(1):4-12. PubMed ID: 19181602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin resistance in chronic hepatitis C: association with genotypes 1 and 4, serum HCV RNA level, and liver fibrosis.
    Moucari R; Asselah T; Cazals-Hatem D; Voitot H; Boyer N; Ripault MP; Sobesky R; Martinot-Peignoux M; Maylin S; Nicolas-Chanoine MH; Paradis V; Vidaud M; Valla D; Bedossa P; Marcellin P
    Gastroenterology; 2008 Feb; 134(2):416-23. PubMed ID: 18164296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin resistance and HCV: will new knowledge modify clinical management?
    Negro F
    J Hepatol; 2006 Oct; 45(4):514-9. PubMed ID: 16901576
    [No Abstract]   [Full Text] [Related]  

  • 14. Dysmetabolic changes associated with HCV: a distinct syndrome?
    Lonardo A; Loria P; Carulli N
    Intern Emerg Med; 2008 Jun; 3(2):99-108. PubMed ID: 18274709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic syndrome, non-alcoholic fatty liver disease and hepatitis C virus: impact on disease progression and treatment response.
    Younossi ZM; McCullough AJ
    Liver Int; 2009 Mar; 29 Suppl 2():3-12. PubMed ID: 19187068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis C virus, steatosis and lipid abnormalities: clinical and pathogenic data.
    Negro F; Sanyal AJ
    Liver Int; 2009 Mar; 29 Suppl 2():26-37. PubMed ID: 19187070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic hepatitis C infection and insulin resistance: two best friends.
    Abenavoli L; Almasio PL
    Expert Rev Anti Infect Ther; 2011 Aug; 9(8):555-8. PubMed ID: 21819320
    [No Abstract]   [Full Text] [Related]  

  • 18. Nonalcoholic fatty liver disease and HIV infection.
    Vallet-Pichard A; Mallet V; Pol S
    Semin Liver Dis; 2012 May; 32(2):158-66. PubMed ID: 22760655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Review article: non-alcoholic fatty liver disease and hepatitis C--risk factors and clinical implications.
    Sanyal AJ
    Aliment Pharmacol Ther; 2005 Nov; 22 Suppl 2():48-51. PubMed ID: 16225473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic alterations and hepatitis C: From bench to bedside.
    Chang ML
    World J Gastroenterol; 2016 Jan; 22(4):1461-76. PubMed ID: 26819514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.